What Is Apidra and How Does It Work?
Apidra is a fast-acting insulin that controls blood sugar levels in people with diabetes. The active ingredient in Apidra is insulin glulisine, a synthetic version of human insulin. Insulin glulisine helps to lower blood sugar by moving glucose from the blood into the body’s cells, which can be used for energy. Apidra works quickly, lowering blood sugar within 15 minutes after injection. Because of its rapid action, it is typically taken around mealtimes to manage the spike in blood sugar after eating. Apidra is approved for use in both adults and children with diabetes, helping to improve glycemic control in those with Type 1 and Type 2 diabetes.
Usage
Apidra is approved for people with Type 1 and Type 2 diabetes. It is commonly used in patients who require rapid-acting insulin to control blood sugar levels around mealtimes. It can be used in adults and children, but it is only approved for use in pediatric patients 4 years or older. There is no evidence supporting its safety or effectiveness in children under 4 years old or in children with Type 2 diabetes, so it should not be used in these groups. Additionally, people with hypersensitivity to insulin glulisine or its ingredients should avoid using Apidra.
Administration
Apidra can be administered differently depending on the patient’s needs and preferences. The main methods of administration include:
- Subcutaneous Injection: Apidra can be injected into the abdomen, thigh, or upper arm. It should be injected within 15 minutes before a meal or within 20 minutes after starting a meal. Injection sites within the same region should be rotated to minimize the risk of lipodystrophy (fat tissue changes) and localized cutaneous amyloidosis (skin issues). Apidra is often used alongside an intermediate or long-acting insulin.
- Continuous Subcutaneous Infusion (Insulin Pump): Apidra can also be administered using an insulin pump. The infusion site should be rotated regularly to prevent lipodystrophy and localized cutaneous amyloidosis. It’s important not to dilute or mix Apidra when using an external insulin pump.
- Intravenous Administration: Apidra can be administered intravenously under medical supervision. For this method, it needs to be diluted to a concentration between 0.05 and 1 unit/mL in 0.9% sodium chloride injection (saline) using polyvinyl chloride infusion bags.
Dosage Forms and Strengths
Apidra is available in two different forms to accommodate various needs. The 10 mL Apidra vial is a multi-dose container designed for syringes or insulin pumps, providing flexibility for patients who need to administer multiple doses from a single vial. Alternatively, the 3 mL Apidra SoloStar prefilled pen is a convenient, single-use device that comes pre-loaded with insulin, offering an easy and portable option for those who prefer an injection pen. Both forms provide the same fast-acting insulin glulisine to help manage blood sugar levels.
How Do You Adjust Your Apidra Dosage?
Several factors can affect how your insulin dosage should be adjusted to ensure proper blood sugar control:
- Changes in Physical Activity: Increased physical activity typically lowers blood glucose levels, so you may need to reduce your Apidra dose to avoid hypoglycemia. Conversely, if your activity level decreases, you may need to increase the dose to maintain proper glucose levels.
- Meal Patterns and Illness: Your dose is closely linked to the amount and type of food you eat. You may need to increase your dose if you consume more carbohydrates than usual. On the other hand, if you’re eating less due to illness or other reasons, a lower dose may be necessary to prevent low blood sugar. Illnesses, especially those that cause fever or stress, can also affect your insulin needs by raising blood glucose levels.
- Renal or Hepatic Impairment: If you have kidney (renal) or liver (hepatic) issues, your body may not metabolize insulin as efficiently, affecting how much you need. Renal or hepatic impairment often requires lower insulin doses, as these conditions can make the insulin stay in your system longer.
- Switching from Other Insulin Types: When transitioning from other insulin types to Apidra, dosage adjustments may be necessary. Fast-acting insulins like Apidra have different onset and duration times than long-acting or regular insulins. Your doctor will typically reduce your previous insulin dose to ensure you don’t experience hypoglycemia when switching to Apidra.
Warnings and Precautions
There are several important warnings and precautions to consider when using Apidra:
Hypoglycemia
This is the most common side effect of insulin, including Apidra. Hypoglycemia (low blood sugar) can happen if you take too much insulin, skip a meal, increase physical activity, or make other changes in your routine. Symptoms of hypoglycemia include sweating, shakiness, confusion, and rapid heartbeat. To prevent hypoglycemia, monitoring your blood sugar regularly is essential, adjusting your insulin dose according to your meal and activity levels, and always carrying fast-acting glucose (like glucose tablets or juice) to treat low blood sugar quickly.
Hypokalemia
Insulin can cause a drop in potassium levels (hypokalemia) in the blood, which can be life-threatening if not managed. Low potassium can lead to heart rhythm problems or muscle weakness. Patients at risk for low potassium levels, such as those on certain medications (like diuretics), need regular monitoring of their potassium levels, especially when starting or adjusting insulin therapy.
Allergic Reactions
Severe allergic reactions are rare but can occur. Symptoms of a serious reaction include rash, swelling, shortness of breath, fast heartbeat, and low blood pressure (anaphylaxis). If any of these symptoms occur, medication should be discontinued immediately, and emergency medical care should be sought. For milder reactions, such as localized swelling or itching at the injection site, treatment may include rotating injection sites or using antihistamines.
Insulin Pump Device Malfunction
If you use an insulin pump, a malfunction can cause rapid hyperglycemia (high blood sugar) or even lead to diabetic ketoacidosis (DKA), a serious condition. If your pump fails or an infusion set becomes blocked, you must switch to subcutaneous insulin injections until the problem is resolved. Always have a backup insulin delivery system ready in case of pump failure.
Heart Failure and TZDs (Thiazolidinediones)
Taking Apidra with certain diabetes medications called TZDs (e.g., pioglitazone) can cause or worsen heart failure. Signs of heart failure include shortness of breath, swelling in the legs, and rapid weight gain. If these symptoms occur, you should contact your doctor immediately, and your TZD dose may need to be reduced or discontinued.
Side Effects
Common side effects include:
- Hypoglycemia: The most frequent side effect, which can cause symptoms like dizziness, shakiness, and confusion.
- Allergic Reactions: Some patients may experience swelling, redness, or itching at the injection site.
- Weight Gain: Like other insulins, Apidra can cause a slight increase in weight.
Serious side effects include severe hypoglycemia, low potassium levels (hypokalemia), fluid retention, and the risk of heart failure when used with thiazolidinediones (TZDs).
Drug Interactions
Several drugs can interact with Apidra and either increase or decrease its blood sugar-lowering effects:
- Drugs That Increase Hypoglycemia Risk: Certain medications, such as oral antidiabetic drugs, ACE inhibitors, fibrates, and salicylates, can increase the risk of hypoglycemia. If you take these medications, more frequent blood glucose monitoring is necessary, and you may need to adjust your insulin dose accordingly.
- Drugs That Decrease Insulin Effectiveness: Some medications, like corticosteroids, diuretics, and thyroid hormones, can reduce the effect of insulin, leading to higher blood glucose levels. In these cases, an increase in dose may be needed.
- Medication Errors and Proper Insulin Labeling: Accidental mix-ups between different types of insulin can lead to serious consequences, such as hypoglycemia or hyperglycemia. To avoid errors, always double-check the insulin label before each injection.
- Drugs That Blunt Hypoglycemia Symptoms: Medications like beta-blockers and clonidine can mask the warning signs of hypoglycemia, such as rapid heartbeat or shakiness. People taking these drugs should observe their blood sugar more frequently, as they may not recognize the onset of low blood sugar.
Storage
Proper storage and handling of drug is essential for maintaining its effectiveness:
Unopened Apidra
Unopened vials and SoloStar pens should be stored in the refrigerator at temperatures between 36°F and 46°F (2°C–8°C). Do not freeze
. If the insulin is accidentally frozen, it must be discarded. Keep it away from direct heat and light while in storage.
Opened Apidra
- Vials: Once a vial is opened, it can be stored either in the refrigerator or at room temperature (below 77°F/25°C). Opened vials must be used within 28 days, after which any remaining insulin should be discarded.
- SoloStar Pen: After opening a SoloStar prefilled pen, it should be kept at room temperature and should not be refrigerated. Discard the pen after 28 days, even if there is still insulin remaining.
When using Apidra in insulin pumps, infusion sets (reservoirs, tubing, and catheters) should be changed every 48 hours to prevent infection and ensure proper insulin delivery. The insulin should be discarded if it is exposed to temperatures higher than 98.6°F (37°C). It’s important to have a backup insulin delivery method in case of pump failure.
How to Use
Proper usage of Apidra is key to managing blood glucose levels effectively:
Self-Injection Techniques
Patients using Apidra for subcutaneous injections should inject it into the abdomen, thigh, or upper arm and rotate injection sites to avoid skin complications such as lipodystrophy. To control post-meal blood glucose spikes, it should be injected within 15 minutes before a meal or within 20 minutes after starting a meal.
Importance of Not Sharing SoloStar Pens or Syringes
Patients must be aware that they should never share their SoloStar insulin pen or syringes with anyone, even if the needle is changed. Sharing insulin pens or syringes can lead to the transmission of serious infections.
Special Considerations for Patients Using Insulin Pumps
For those using insulin pumps, following the pump manufacturer’s instructions and regularly rotating infusion sites to prevent skin complications is important. Patients should also be prepared with a backup plan, like subcutaneous injections, in case the pump malfunctions.
Importance of Frequent Glucose Monitoring
Frequent blood sugar monitoring is crucial, especially when starting or adjusting doses. Blood sugar levels should be checked regularly to prevent hypoglycemia or hyperglycemia, particularly after meals or changes in physical activity.
Special Populations
When considering the use of Apidra in special populations such as pregnant or lactating women, it’s important to note the following:
Use in Pregnancy
There is no conclusive evidence that Apidra increases the risk of birth defects. However, it is essential for pregnant women with diabetes to maintain tight blood sugar control to minimize risks to both the mother and the baby, such as preterm birth and stillbirth. If used during pregnancy, a doctor should carefully monitor to ensure optimal glycemic control.
Lactation Considerations
Apidra is believed to pass into breast milk in small amounts, but there have been no reported adverse effects on breastfed infants. Lactating women can use this medicine provided they continue to observe their blood sugar levels closely.
